Trials / Completed
CompletedNCT03898934
Vitamin D Supplementation in PCOS Patients
Dose Vitamin-D Supplementation Affect Reproductive Outcomes in Patients With Polycystic Ovary Syndrome?
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 170 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
To assess whether Vitamin D supplementations for patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not
Detailed description
This study is double blinded randomized controlled study conducted at Tanta University hospitals in the period from April 2019 to March 2022. Patients and methods: One hundred twelve patients were recruited and randomly allocated into 2 groups; study group with Vitamin D supplementation and control group without Vitamin D supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D | receive 6000iu daily for 8 weeks |
| DRUG | Placebo Oral Tablet | placebo for the same period |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2022-03-30
- Completion
- 2022-03-31
- First posted
- 2019-04-02
- Last updated
- 2022-05-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03898934. Inclusion in this directory is not an endorsement.